Lead Optimization
Once a selection of hits has been identified, the process of drug discovery moves to refine initial hits with promising biological activity into validated leads that are optimized for potency, selectivity, and drug-like properties. Lead optimization typically takes 1-2 years, and is a process of iteration: repeated compound cycles, evolving assays, and shifting definitions of what is “optimized”1. These procedures can be plagued with inconsistent data capture and slow cross-team visibility across biology, DMPK, and safety. But when faced with these challenges, Leadscope Model Applier™ can be used to support science-based conclusions.
Instem’s products are not one-dimensional; the platforms can support multiple stages of drug discovery. In addition to target identification and discovery, Centrus® and BioRails® can also be beneficial for lead optimization:
- Centrus® can continue to support safety intelligence as candidate properties and risks evolve in the process of lead optimization.
- BioRails® can help teams manage and analyze experimental pipelines in a unified way, reducing fragmentation across studies and assay outputs as leads are optimized.
These solutions support iterative processes by allowing analysis and risk assessment to keep pace with the pharmaceutical company’s needs.
For Advanced Toxicology Insights: Leadscope Model Applier™
Researchers conducting lead optimization need to predict toxicity endpoints, review results, and occasionally generate regulatory-compliant reports. Leadscope Model Applier is a software solution capable of providing robust toxicology assessments with modules that support ICH M7 and other global guidelines.
Leadscope Model Applier has access to a toxicity database of over 600,000 experiments covering over 200,000 chemicals. Modules can assess pharmaceutical impurities, skin sensitization, oral toxicity, enzyme inhibition, and N-nitrosamine intake, enabling comprehensive safety and chemical risk assessments with ease and reducing the need for expensive, time-consuming in vitro or in vivo studies.
Through predictive toxicology, unified data management, and advanced analytics, Instem ensures that lead optimization stays aligned with both scientific goals and safety standards. The result is a smoother, more confident path toward preclinical evaluation. In the next article, we explore how Instem elevates preclinical efficacy studies with modernized workflows and end‑to‑end data integrity.
1. Macdonald SJF, Smith PW. Lead optimization in 12 months? True confessions of a chemistry team. Drug Discov Today. 2001;6(18):947-953. doi:10.1016/S1359-6446(01)01937-7
